- We study the pathogenesis of neuronal disorders
to develop therapeutics and biomarkers
for neurodegenerative and dementia diseases. - Our current interests include molecular and neuronal function,
neuronal circuit alteration, and behavior impairments,
involved in amyotrophic lateral sclerosis (ALS),
frontotemporal lobar degeneration (FTLD), tauopathies, and Alzheimer’s disease.
-
- Elucidation of pathomechanisms of frontotemporal lobar degeneration (FTLD) spectrum disorders including FTLD, amyotrophic lateral sclerosis (ALS), and other tauopathies.
-
- Investigation of molecular function of FUS and tau using animal models.
-
- Development of novel biomarkers focusing on higher brain dysfunction observed in FTLD.
-
- Development of oligonucleotide therapeutics based on the molecular functions of FUS and tau.
-
- Development of next-generation imaging diagnostic methods for Alzheimer’s disease.
-
- Development of diagnostics and therapeutics for Alzheimer’s disease.
- Publications
- This section introduces major research achievements such as academic papers published so far.
News
-
- 2024.08.24Conference
- “Tau Meeting 2024” was held on August 23-24 at SUMS
-
- 2024.05.10Published
- Dr.Fujioka’s paper has been accepted and published in Front Neurosci.
-
- 2024.04.02Information
- Mr.Ankhabayar and Mr.Nguyen have enrolled in a doctoral program at the graduate school